Inovio Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018

    NEXT STORY
    Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009
    PREV STORY
    Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Philips data-driven Mask Selector delivers unique patient and business benefits

    author_avatar
    NASDAQ Market News

    GeoVax HIV Clinical Trials Update

    ATLANTA, GA--(Marketwired - Nov 15, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology ...

    author_avatar
    NASDAQ Market News

    Novartis receives positive CHMP opinion for Tafinlar® + Mekinist® in BRAF-positive non-small cell lung cancer (NSCLC) patients

    If approved, Tafinlar + Mekinist will be the first targeted therapy specifically for NSCLC ...

    author_avatar
    NASDAQ Market News